CARAMORI, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 20.324
AS - Asia 12.041
EU - Europa 7.046
SA - Sud America 2.135
AF - Africa 255
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 11
Totale 41.856
Nazione #
US - Stati Uniti d'America 19.946
SG - Singapore 4.359
CN - Cina 3.082
BR - Brasile 1.654
IT - Italia 1.627
UA - Ucraina 1.515
VN - Vietnam 1.387
DE - Germania 1.132
HK - Hong Kong 1.097
TR - Turchia 849
GB - Regno Unito 648
FI - Finlandia 581
FR - Francia 434
RU - Federazione Russa 325
JP - Giappone 305
SE - Svezia 258
IN - India 206
MX - Messico 200
PL - Polonia 195
AR - Argentina 176
BD - Bangladesh 139
CA - Canada 131
ID - Indonesia 128
IQ - Iraq 95
ZA - Sudafrica 90
EC - Ecuador 70
NL - Olanda 69
CO - Colombia 65
PK - Pakistan 58
PY - Paraguay 43
PH - Filippine 39
VE - Venezuela 39
AU - Australia 38
ES - Italia 38
MA - Marocco 37
CL - Cile 36
UZ - Uzbekistan 33
AE - Emirati Arabi Uniti 32
MY - Malesia 32
SA - Arabia Saudita 32
BE - Belgio 31
LT - Lituania 30
KE - Kenya 26
TN - Tunisia 26
EG - Egitto 25
PE - Perù 21
UY - Uruguay 20
AT - Austria 19
KZ - Kazakistan 19
CH - Svizzera 18
IE - Irlanda 18
CZ - Repubblica Ceca 17
KR - Corea 17
NP - Nepal 17
RO - Romania 15
TW - Taiwan 13
AL - Albania 12
BG - Bulgaria 12
IL - Israele 11
CR - Costa Rica 10
DZ - Algeria 10
JO - Giordania 10
LB - Libano 10
ET - Etiopia 9
AZ - Azerbaigian 8
BO - Bolivia 8
IR - Iran 8
OM - Oman 8
BY - Bielorussia 7
EU - Europa 7
BH - Bahrain 6
HU - Ungheria 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
DO - Repubblica Dominicana 5
HN - Honduras 5
HR - Croazia 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
TT - Trinidad e Tobago 5
CI - Costa d'Avorio 4
GR - Grecia 4
GT - Guatemala 4
MN - Mongolia 4
NI - Nicaragua 4
PS - Palestinian Territory 4
RS - Serbia 4
SV - El Salvador 4
TH - Thailandia 4
AO - Angola 3
CG - Congo 3
KH - Cambogia 3
MM - Myanmar 3
MU - Mauritius 3
NO - Norvegia 3
PR - Porto Rico 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
Totale 41.805
Città #
Singapore 2.725
Fairfield 2.049
Woodbridge 1.897
Ashburn 1.852
Jacksonville 1.590
Houston 1.221
Chandler 1.143
Hong Kong 1.088
San Jose 945
Santa Clara 866
Ann Arbor 861
Wilmington 765
Seattle 723
Beijing 717
Cambridge 590
Izmir 534
Nanjing 527
Ho Chi Minh City 459
Princeton 330
Munich 318
Hanoi 311
Tokyo 290
Lauterbourg 257
Helsinki 235
Milan 229
Los Angeles 227
Washington 214
New York 198
Dallas 191
Warsaw 186
San Diego 179
Ferrara 153
Boardman 144
Shenyang 144
Mexico City 140
São Paulo 133
Nanchang 132
Hebei 101
Changsha 93
Tianjin 90
Jiaxing 87
Addison 86
Hefei 84
Shanghai 83
Chicago 78
Rome 77
Dearborn 69
Council Bluffs 63
Da Nang 60
London 60
Haiphong 59
Jinan 59
Moscow 58
Toronto 55
Orem 54
Rio de Janeiro 54
Brooklyn 50
Chennai 50
Jakarta 49
Verona 48
Buffalo 46
Norwalk 46
Kunming 45
Frankfurt am Main 42
Zhengzhou 40
Guangzhou 39
Naples 39
Redwood City 38
Ningbo 37
Turku 37
Baghdad 36
Falls Church 36
Mountain View 36
Johannesburg 35
Boston 34
The Dalles 34
Belo Horizonte 33
Hải Dương 33
Bologna 31
Curitiba 30
Atlanta 29
Taizhou 29
Montreal 28
Campinas 27
Denver 27
Brussels 26
Bremen 25
Mumbai 25
Orange 24
Poplar 24
Quito 24
Tashkent 24
Amsterdam 23
Biên Hòa 23
Bogotá 23
Brasília 22
Guayaquil 22
Istanbul 22
Manchester 22
Porto Alegre 22
Totale 27.368
Nome #
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 445
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 378
Expiratory flow limitation as a risk factor for pulmonary complications after major abdominal surgery 353
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 337
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 335
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 304
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 301
Targeting Th2 cells in asthmatic airways 297
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 274
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 251
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 247
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 241
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 234
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 230
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 224
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 216
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 209
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 208
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 208
Malattie polmonari primitive da cause dismetaboliche. 205
Sindrome epatopolmonare. 205
Activation of NF-kappaB transcription factor in asthma death 204
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 200
Airway obstruction in chronic obstructive pulmonary disease. 200
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 199
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 199
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 199
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 197
Cellule staminali e patologia polmonare dell’adulto 196
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes 195
Models of infection and exacerbations in COPD. 189
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 189
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 188
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 188
A link between lung injury and inflammatory myopathies: making the diagnosis 187
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 187
Definition, clinical features, investigations and differential diagnosis in asthma. 186
Severe Pneumonia following intravescical BCG therapy in a patient with bladder cancer. 184
COPD exacerbations: definitions and classifications 182
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 182
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 181
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 179
Definizione e classificazione delle broncopneumopatie croniche ostruttive. 177
Birbeck granules: contribution to the comprehnsion of intracytoplasmic evolution 177
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 176
Extrapulmonary tuberculosis 176
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare. 175
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 175
Convergent sets of data from In Vivo and In Vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis 175
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 175
Ectopic thymoma simulating a pericardial cyst: case report 175
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 174
Corticosteroidi, disodiocromoglicato e nedocromile nella terapia dell’asma bronchiale e delle broncopneumopatie croniche ostruttive. 173
Asthma: A Chronic Infectious Disease? 173
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus 172
Allergen responses modified by a GATA3 DNAzyme 171
STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects 170
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 170
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 170
Molecular mechanisms of respiratory virus-induced inflammation. 166
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression 166
Clinical definition of COPD exacerbations and classification of their severity 165
Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study 164
Anti-inflammatory treatments for asthma: Past, present, future 163
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 163
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 163
Mechanisms involved in lung cancer development in COPD 162
Chronic obstructive pulmonary disease international guidelines 162
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 161
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 161
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 161
Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease 160
Therapies acting on transcription: overview. 160
Near-fatal asthma phenotype in the ENFUMOSA cohort 159
Steroid-sparing Strategies: Other Combinations 159
Interactions of airway pathogens and inflammatory processes 158
Pathophysiology of viral-induced exacerbations of COPD 155
New insights into the molecular mechanisms of corticosteroids actions 155
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 155
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 154
Transcription Factors: Overview 154
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations 154
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: An overview 153
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 153
Anatomia e fisiologia clinica della pleura. 153
Gender and respiratory infections. 151
Chronic Obstructive pulmonary disease and lung cancer: New molecular insights 150
Respiratory mechanics at different PEEP level during Anaesthesia in elderly: a pilot study. 150
Interactions of airway pathogens and inflammatory processes 150
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 149
The level of control of mild asthma in general practice: An observational community-based study 149
Malattie della pleura 148
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 148
Asma e leucotrieni 148
COPD immunopathology 148
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation 147
Novel anti-inflammatory treatments for asthma and COPD 147
Strategies for improving the efficacy and therapeutic ratio of glucocorticoids 146
The future of relievers and controllers in asthma therapy. 146
STAT2 activation in smokers and patients with chronic obstructive pulmonary disease 145
Totale 19.028
Categoria #
all - tutte 181.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 29.032
Totale 210.609


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.108 0 0 0 0 0 0 0 0 0 423 437 248
2021/20222.567 61 286 199 218 74 94 99 163 93 235 265 780
2022/20232.619 350 61 78 324 375 457 69 244 360 25 183 93
2023/20241.103 148 171 53 30 86 139 27 47 23 37 42 300
2024/20255.145 186 114 429 135 636 401 192 414 848 734 587 469
2025/202614.391 1.218 906 1.451 2.132 2.080 962 1.552 1.108 1.478 1.504 0 0
Totale 42.163